cti  the pain mitigation company  home homeabout∨profilewho we areboard of directorsservices∨overviewlicensingtechnology sourcingtechnologies∨featured technologiesportfolionews  press∨currentinvestors∨cti at a glanceboard of directorswho we aresec filingscorporate governanceinvestor contactscontact∨corporate officesinvestor contacts calmare therapeutics incorporated otcqb cttc cti is a biotherapeutic company furthering proprietary and patented pain mitigation and wound care technologies our medical devices offer a nonpharmacological no drugs nonaddictive no narcotics and noninvasive “over the skin” solution to chronic pain sufferers in an outpatient treatment setting cti supplements our medical devices with a catalogue of private label neurostimulation and sensory electrodes the company has fda k medical clearance k for sales in the united states and reciprocity countries for its flagship medical device  the calmare® pain therapy device we sell our devices in europe under cemark designation that was issued by the european commission’s competitiveness and innovation program in  commercial sales are also made throughout the world under the guidance and jurisdiction of the respective countries’ ministry of health department for more information on the device visit wwwcalmarepmtcom the company has been a preferred vendor of the us federal government gsavpb since  devices consumables and related hardware are sold to us military hospitals and clinics throughout the united states the calmare® pain therapy device provides excellent pain treatment efficacy through a noninvasive procedure which successfully treats pain without harmful side effects or the use of powerful and potentially addictive drugs dr jonathan kost of the hartford hospital pain treatment center discusses use of the calmare pain therapy device in the treatment of chemotherapyinduced peripheral neuropathy whats new cti board of directors changes cti medical device and peripherals listed for sale on gsa advantage® cti reports rd quarter  results media coverage ehealth radio interviews dr stephen damato chief medical officer of calmare therapeutics the osgood file hosted by charles osgood on the cbs radio network covers research utilizing the calmare® pain therapy medical device being conducted at the mayo clinic the syndicated television show the doctors interviews dr jack dangelo and discusses his use of the calmare® pain therapy medical device to treat complex regional pain syndrome follow cti  sunday july rd  terms of service  privacy  legal  sitemap   copyright calmare therapeutics incorporated   cti  contact cti  corporate offices homeabout∨profilewho we areboard of directorsservices∨overviewlicensingtechnology sourcingtechnologies∨featured technologiesportfolionews  press∨currentinvestors∨cti at a glanceboard of directorswho we aresec filingscorporate governanceinvestor contactscontact∨corporate officesinvestor contacts corporate offices you may reach the cti team using the following contact information calmare therapeutics incorporated calmare therapeutics incorporated  kings hwy ste  fairfield ct  email this email address is protected javascript must be enabled to view it tel  fax  quick links corporate offices investor contacts sunday july rd  terms of service  privacy  legal  sitemap   copyright calmare therapeutics incorporated   cti  about cti  profile homeabout∨profilewho we areboard of directorsservices∨overviewlicensingtechnology sourcingtechnologies∨featured technologiesportfolionews  press∨currentinvestors∨cti at a glanceboard of directorswho we aresec filingscorporate governanceinvestor contactscontact∨corporate officesinvestor contacts profile calmare therapeutics incorporated otcqb cttc cti  the calmare pain mitigation therapy™ company researches develops and commercializes chronic neuropathic pain and wound affliction devices our flagship medical device  the calmare® pain therapy device  is the worlds only noninvasive and nonaddictive modality that can successfully treat chronic neuropathic pain the company holds a us food  drug administration k clearance designation k on its flagship device which grants it the exclusive right to sell market research and develop the medical device in the united states calmare devices are commercially sold to medical practices throughout the world they are also found in us military hospitals clinics and on installations via ctis general services administration gsa military contract vpb headquartered in fairfield connecticut in  more than  chronic pain patients have been successfully treated with calmare pain mitigation therapy™ since the first calmare chronic pain treatment was administered in  quick links profile who we are board of directors cti has a world class team of professionals with diverse technical legal intellectual property marketing and business experience sunday july rd  terms of service  privacy  legal  sitemap   copyright calmare therapeutics incorporated   cti  services  technology sourcing homeabout∨profilewho we areboard of directorsservices∨overviewlicensingtechnology sourcingtechnologies∨featured technologiesportfolionews  press∨currentinvestors∨cti at a glanceboard of directorswho we aresec filingscorporate governanceinvestor contactscontact∨corporate officesinvestor contacts technology sourcing calmare therapeutics technology sourcing service actively seeks technologies that fit with customer business objectives and presents them as potential licensing or intellectual property acquisition candidates cti leverages its inventory of exclusive technologies and its extensive technologysourcing network to identify and commercialize technologies that fulfill unsatisfied technology needs cti customers increase their own profitability by outsourcing to cti the process of searching for technology cti offers their customers access to numerous sources of client technologies in various stages of development early middle or readytomarket technologies according to customer needs quick links overview licensing technology sourcing sunday july rd  terms of service  privacy  legal  sitemap   copyright calmare therapeutics incorporated   cti  investor relations  overview homeabout∨profilewho we areboard of directorsservices∨overviewlicensingtechnology sourcingtechnologies∨featured technologiesportfolionews  press∨currentinvestors∨cti at a glanceboard of directorswho we aresec filingscorporate governanceinvestor contactscontact∨corporate officesinvestor contacts welcome investors annual meeting presentation  october   xbrl interactive data beginning with ctis second quarter  form q you may obtain the companys financial statements in interactive data xbrl format click on the link following the xbrl icon to download the xbrl files form q rdq fy  xbrlform q ndq fy  xbrlform q stq fy  xbrlform k fiscal  xbrl december   consolidated statements sec filingspress releases  news for further inquiries please contact conrad f mir calmare therapeutics incorporated tel  email this email address is protected javascript must be enabled to view it quick links cti at a glance board of directors who we are sec filings corporate governance investor contacts delayed minimum  minutes last trade volume change intraday range note some of the files located within this site are in the adobe pdf format sunday july rd  terms of service  privacy  legal  sitemap   copyright calmare therapeutics incorporated   cti  services  licensing homeabout∨profilewho we areboard of directorsservices∨overviewlicensingtechnology sourcingtechnologies∨featured technologiesportfolionews  press∨currentinvestors∨cti at a glanceboard of directorswho we aresec filingscorporate governanceinvestor contactscontact∨corporate officesinvestor contacts licensing cti develops relationships worldwide with companies who have technology requirements ctis strong global network of relationships and customized licensing programs maximizes commercialization of clients technologies and decreases timetomarket cti uses a highly skilled staff of legal business scientific engineering and administrative professionals to evaluate client technologies ctis clients including universities corporations and inventors benefit from ctis expertise for the most effective way to market their technologies to the global marketplace cti and its clients share the license andor royalty fees paid by cti customers for technologies license management services including royalty collection distribution and auditing are a part of ctis client services in the process of carrying out its responsibilities cti also has skills in patent application and analysis and managing patent enforcement litigation quick links overview licensing technology sourcing sunday july rd  terms of service  privacy  legal  sitemap   copyright calmare therapeutics incorporated   cti  legal homeabout∨profilewho we areboard of directorsservices∨overviewlicensingtechnology sourcingtechnologies∨featured technologiesportfolionews  press∨currentinvestors∨cti at a glanceboard of directorswho we aresec filingscorporate governanceinvestor contactscontact∨corporate officesinvestor contacts terms of service privacy statement rss terms of service dmca notices effective date october   terms of service calmare therapeutics incorporated cti maintains the web site calmaretherapeuticscom the site for your information education communication and personal enjoyment access to and use of this site are subject to the terms and conditions set forth below cti makes no representations or warranties as to the accuracy reliability or completeness of the information text graphics links content or other items contained in the site or in any site linked to or from the site cti expressly disclaims liability for any errors or omissions in the materials contained in the site or in any site linked to or from the site cti reserves the right to make changes in the programs policies products and services described in this site at any time without notice the information and materials contained in this site are provided to you as is and your use of this site or any site linked to or from this site is solely at your own risk cti makes no warranties of any kind whether express or implied including but not limited to the implied warranties of merchantability fitness for a particular purpose or noninfringement cti shall have no responsibilities to update any content or information contained on the site cti expressly disclaims any liability contingent or otherwise for any damage to or viruses that may infect your computer or other property due to your use of this site or any site linked to or from this site or your downloading of any materials text or images from the site or from any site linked to or from the site cti shall not be liabile for any direct indirect consequential special incidental or punitive damages arising out of your access to or use of this site or any site linked to or from this site for our customers convenience cti provides links to other sites in addition links to this site may be provided from other sites either known or unknown to cti cti is not responsible for the content of any site that is linked to or from this site the fact that another site is linked to or from this site does not imply that a cti sponsors licenses authorizes endorses is affiliated with or is otherwise connected to such site the products or services described therein or its owners or providers or b cti has authorized the linked site to use any trademark trade name logo or other trademarked or copyrighted material of cti the trademarks service marks trade names logos and other indications of origin displayed in this site trademarks are owned by cti or a third party who has granted cti a right to use them in this site such third parties shall have no liability to you for monetary damages on account of any trademarks displayed herein nothing contained herein should be construed as granting the browser or user of this site the right to use any trademark displayed in this site without the written permission of the owner of the trademark these web site terms of service are not intended to and will not transfer or grant any rights in or to the contents of the site other than those which are specifically described herein any materials communications or information sent to this site information will be deemed not confidential and nonproprietary and will become the property of cti cti may use such information for any purpose whatsoever including but not limited to the use of any ideas concepts knowhow or techniques contained in the information cti may reproduce display transmit perform publish and broadcast the information at any time and in any media cti reserves the right at anytime and from time to time in its own business judgment to add remove revise or modify any of the contents of the site including these web site terms of service you agree that your continued access and use of this site shall bind you to any new terms or conditions that may be posted on this site from time to time and that you are required to read the same neither cti nor any third party shall have any responsibility to maintain the information or content made available on the site or to supply any corrections updates or releases in connection therewith availability of information and content are subject to change without notice copyright  permissions materials available on the site are protected by the copyright laws of the united states and other countries copyright calmare therapeutics incorporated   all rights reserved when you access the site you agree to the following terms of use you may retrieve the contents of the site for informational purposes only you may save a local copy or send it to your printer for your own personal use however you may not charge any fees or other form of compensation or remuneration for such use you are not permitted to publish transmit or otherwise reproduce the contents of the site in whole or in part in any format to any third party without the express written consent of cti you must include the copyright notice in any copy that you make and you are not permitted to alter obscure or remove any such copyright any trademark or any other notices that are provided to you in connection with the contents of the site you may not modify the information found in the site without the express permission of cti linking to this site all links to this site must be approved in writing by cti except that cti consents to links in which the link and the pages that are activated by the link do not a create frames around any page on this site or use other techniques that alter in any way the visual presentation or appearance of any content within this site b misrepresent your relationship with cti c imply that cti approves or endorses you your web site or your service or product offerings and d present false or misleading impressions about cti or otherwise damage the goodwill associated with the cti name or trademarks as a further condition to being permitted to link to this site you agree that cti may at any time in its sole discretion terminate permission to link to this site in such event you agree to immediately remove all links to this site and to cease using any cti trademark effective date october   cti online privacy statement calmare therapeutics incorporated and its subsidiaries and affiliates collectively cti respect your privacy and are committed to protecting it please read this cti online privacy statement the privacy policy to be informed of our privacy policy and practices and about the way your information is collected online the privacy policy applies to personal and technology information collected by cti through its web site calmaretherapeuticscom the site personal information means any information that may be used to identify an individual including but not limited to a first and last name a home or other physical address and an email address or other contact information whether at work or at home in general you can visit the site without telling us who you are or revealing any personal information about yourself technology information means any information you submit to cti for evaluation or review or for any other purpose through the site which relates to technologies intellectual property or the like you can also visit the site without submitting or revealing any technology information cti strives to comply with all applicable laws that are designed to protect your privacy sites covered by privacy policy the site may provide links to thirdparty web sites for your convenience and information if you access those links you will leave the site cti does not control these web sites or their privacy practices which may differ from the sites we do not endorse or make any representations about thirdparty web sites the personal information or technology information you choose to give to unrelated third parties is not covered by our privacy policy we encourage you to review the privacy policy of any company before submitting your personal information or technology information our commitment to the privacy of children cti is committed to protecting the privacy needs of children cti does not knowingly collect information from children under the age of  and no part of the site is structured to attract any person under the age of  how we use your information cti uses your personal information andor technology information collectively information to provide you with services and to help us better understand your needs and interests specifically we use your information to communicate with you and to provide service and support if you choose to have a relationship with cti such as a contractual or other business relationship or partnership we will naturally continue to contact you in connection with that business relationship who we share your information with cti will not sell rent or lease your personal information to others cti will not share your information with any third parties without your permission unless to i respond to duly authorized information requests of government authorities ii comply with any law regulation subpoena or court order iii help prevent fraud or to enforce or protect the rights and properties of cti or iv to protect the personal safety of cti employees and third parties on cti property our commitment to data security cti is committed to protecting the information you provide us to prevent unauthorized access or disclosure to maintain data accuracy and to ensure the appropriate use of the information cti has in place appropriate physical electronic and managerial procedures to safeguard and secure the information we collect online your consent by using the site you consent to the terms of our privacy policy and to ctis processing of personal information and technology information should the privacy policy change we intend to take every reasonable step to ensure that these changes are brought to your attention by posting all changes prominently on our website for a reasonable period of time effective date of privacy policy this privacy policy is effective as of october   how to contact us cti welcomes your comments regarding this privacy policy if you have questions about the privacy policy or believe that we have not adhered to it please contact us by emailing your comments to this email address is protected javascript must be enabled to view it or by mailing your comments to us at cti privacy policy calmare therapeutics incorporated  kings hwy ste  fairfield ct  effective date april   rss terms of service these rss terms of service ctis privacy policy and our general terms of service govern your use of rss content provided by cti any uses of rss content not granted herein are strictly prohibited prohibited uses include but are not limited to the incorporation of advertising or the placement of advertising associated with or targeted at the rss content you may not edit or modify the rss feeds in any manner whatsoever rss feeds may be used only with platforms with a functional link which takes the viewer directly to the full article on the site you may not insert any intermediate page splash page or any other content between the rss link and the applicable article on the site cti retains all ownership and other rights in the rss content and in any and all cti logos and trademarks used in connection with rss feeds if you provide attribution using a graphic you must use the appropriate cti logo incorporated into the rss content or feed cti reserves the right to cease offering any or all of the rss feeds at any time or to require you to cease distributing any or all of the feeds at any time for any reason cti assumes no liability for your activities in connection with the rss feeds or for your use of the feeds in connection with your web site effective date april   digital millennium copyright act notices it is the policy of calmare therapeutics incorporated cti to respect the intellectual property of others and thus to respond to effective notices of alleged infringement of copyrighted material where i the copyrighted material is available at or from a system or network controlled or operated by or for cti or where ii cti by providing or using an information location tool such as a directory index reference pointer or hypertext link refers or links a third party to a site that contains the copyrighted material if you are alleging that copyrighted material may have been or is being infringed then you may notify cti pursuant to the us online copyright infringement liability limitation act of the us digital millennium copyright act  usc § c by sending a notice to the address listed below such notice must include the following to be effective a physical or electronic signature of a person authorized to act on behalf of the owner of an exclusive right that is allegedly infringed identification of the copyrighted work claimed to have been infringed or if multiple copyrighted works at a single online site are covered by a single notification a representative list of such works at that site identification of the material that is claimed to be infringing or to be the subject of infringing activity and that is to be removed or access to which is to be disabled and information reasonably sufficient to permit cti to locate the material information reasonably sufficient to permit cti to contact you such as an address telephone number and if available an electronic mail address at which you may be contacted a statement that you have a good faith belief that use of the material in the manner complained of is not authorized by the copyright owner its agent or the law and a statement that the information in the notification is accurate and under penalty of perjury that you are authorized to act on behalf of the owner of an exclusive right that is allegedly infringed counter notices if material that you have posted to a system or network controlled or operated by or for cti has been removed or disabled you may file a counter notice pursuant to  usc § g to be effective the counter notice must be a written communication sent to the address listed below that includes the following a physical or electronic signature of the subscriber identification of the material that has been removed or to which access has been disabled and the location at which the material appeared before it was removed or access to it was disabled a statement under penalty of perjury that you have a good faith belief that the material was removed or disabled as a result of mistake or misidentification of the material to be removed or disabled and your name address and telephone number and a statement that you consent to the jurisdiction of federal district court for the judicial district in which the address is located or if your address is outside of the united states for any judicial district in which cti may be found and that you will accept service of process from the person who provided notification under subsection  usc § cc or an agent of such person designated agent for all notices including counter notices all written notices should be sent to the following designated agent general counsel calmare therapeutics incorporated  kings hwy ste  fairfield ct  sunday july rd  terms of service  privacy  legal  sitemap   copyright calmare therapeutics incorporated   cttc key statistics  calmare therapeutics inc financial ratios  marketwatch bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close calmare therapeutics inc otc cttc go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus calmare therapeutics inc market closed  quotes are delayed by  min jul    pm cttc quoteszigmandelayed   change   volume volume  quotes are delayed by  min quoteszigmandelayed previous close     change   day low day high    week low  week high   company description calmare therapeutics inc is a medical device company which develops and distributes products and technologies for chronic neuropathic pain and wound care affliction patients its product device calmare pain therepy device is noninvasive and nonaddictive modality that treats chronic neuropath calmare therapeutics inc is a medical device company which develops and distributes products and technologies for chronic neuropathic pain and wound care affliction patients its product device calmare pain therepy device is noninvasive and nonaddictive modality that treats chronic neuropathic pain the company was founded in  and is headquartered in fairfield ct valuation pe current  pe ratio with extraordinary items  price to sales ratio  enterprise value to ebitda  enterprise value to sales  total debt to enterprise value  efficiency revenueemployee  income per employee  receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability gross margin  operating margin  pretax margin  net margin  return on assets  capital structure total debt to total assets  officers and executives name age officer since title mr peter f brennan   chairman mr conrad f mir   president chief executive officer  director mr thomas p richtarich   chief financial officer dr stephen j damato   chief medical officer mr donna j mays   manageradministrative services insider actions – purchase – sale  – number of transactions  date name shares transaction value  rustin r howard director    award at  per share   robert g moussa director    award at  per share   stanley k yarbro director    award at  per share   peter f brennan director    award at  per share   robert g moussa director    award at  per share   peter f brennan director    award at  per share   rustin r howard director    award at  per share   peter f brennan director    award at  per share   william l reali director    award at  per share   joel m evans director    award at  per share   richard d hornidge director    award at  per share   peter f brennan director      peter f brennan director      richard d hornidge director    acquisition at  per share   stanley k yarbro director    acquisition at  per share   stanley k yarbro director    acquisition at  per share  newslatestcompanyuscttc marketwatch news on cttc fund manager finding few bargains among smallcap stocks  pm dec    marketwatch overvalued smallcaps  pm dec    bill disbrow biotech stocks close lower genentech rises  pm oct    val brickates kennedy biotech pharma decline pfizer dips  pm june    val brickates kennedy competitive technologies sued by sec for stock buyback  am aug    heather wilson competitive tech to get m from court ruling  pm june    carla mozee competitive tech wins patent suit against labcorp  pm june    carla mozee is asia out of the woods   pm dec    julie rannazzisi movers and shakers   pm dec    cbsmarketwatchcom commentary zapman thinks we should cenure darlene   pm dec    cbsmarketwatchcom movers and shakers   pm dec    cbsmarketwatchcom soapbox fund managers fight back with ballot box   pm dec    craig tolliver your fund manager is paid too much  pm dec    dr paul b farrell newsnonmarketwatchcompanyuscttc other news on cttc k calmare therapeutics inc  pm july    edgar online  edg  q k q calmare therapeutics inc  pm dec    edgar online  edg  q k q calmare therapeutics inc  pm aug    edgar online  edg  q k innerworkings inwk in focus stock jumps   tale of the tape  am jan    zackscom lb foster boosts inorganic growth on tew engineering buy  analyst blog  pm jan    zackscom turnaround strategy being implemented at competitive technologies  am march    seeking alpha wns holdings beats fiscal q earnings revs up yy  analyst blog  pm jan    zackscom wpp down to buy  analyst blog  am jan    zackscom furmanite corp frm in focus stock up  in session  tale of the tape  am jan    zackscom soufun prices senior notes  analyst blog  pm dec    zackscom wns holdings upped to buy  analyst blog  pm dec    zackscom soufun shares hit week high  analyst blog  am dec    zackscom competitive technologies ceo discusses q  results  earnings call transcript  pm nov    seeking alpha inline q loss at competitive technologies  analyst blog  am nov    zackscom poor q for competitive technologies  analyst blog  pm aug    zackscom competitive technologies short squeeze coming or another leg down  am aug    seeking alpha pain relief coming at competitive technologies  am july    seeking alpha competitive technologies a game changer in pain management  pm may    seeking alpha competitive technologies up on shareholder meeting pending asco presentation  am april    seeking alpha competitive technologies is the pain over  am april    seeking alpha loading more headlines at a glance calmare therapeutics inc  kings highway east suite  fairfield connecticut  phone   industry diversified business services sector businessconsumer services fiscal yearend  view sec filings revenue  net income m employees  annual report for cttc newspressreleasecompanyuscttc press releases on cttc no news currently available for cttc trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aalphabet earnings a  billion hit for google potential youtube results for investors asurprise those ‘great’ companies generally turn out to be meh  or duds athis is how congress could create a bipartisan healthcare bill a fears an ai developer has about artificial intelligence aexhealth insurance ceo  common but faulty beliefs about paying for health care adraining the swamp starts with blowing up health care athese  highly taxed companies need congress to finally act on tax reform abeyond tesla  stocks driving the autonomous car revolution afifty years after the riots detroit is finally rising out of the devastation ayour next online order could be picked out by a robot a costly mistakes people make when buying cars awhat’s a cameo – like ed sheeran on game of thrones – actually worth ptrump says he has ‘complete power to pardon’ plawmakers reach deal on russia sanctions bill reports palphabet earnings a  billion hit for google potential youtube results for investors pyou can date someone who looks just like donald trump with this new online service pwant to buy happiness splurge on these  things pthis is what people really buy when they emotionally overspend hint it’s not designer clothes pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  calmare therapeutics inc cttc this is the biggest competing product to calmare support   newswire  home  log in boards stocks commodities forex cryptocurrency the lounge hot breakout boards ihub my stocks activity ticker buzz cloud most read most posted most followed members recent news active boards site stats new boards cannabis stocks tools data tools  charts trader alerts trades portfolio top lists price  news alerts commodities markets in d newswire more tools  newsletters my image gallery advanced search videos all news stock screener news filter live charts live news live desktop forex prices commodities etf center educational channel personal finance qa streamer level  follow feed home  boards  us otc  medical  equipment  calmare therapeutics inc cttc this is the biggest competing product to calmare public reply  private reply  keep  last readpost new msgreplies   next   previous  next powderbum   followed by  posts  boards moderated  alias born  cttc current price volume bid ask days range cttc detailed quote dmmmmyyyy annual report k edgar us regulatory    pm statement of beneficial ownership sc d edgar us regulatory    pm notification that annual report will be submitted late nt k edgar us regulatory    pm current report filing k edgar us regulatory    pm current report filing k edgar us regulatory    pm statement of ownership sc g edgar us regulatory    am quarterly report q edgar us regulatory    pm current report filing k edgar us regulatory    pm notification that quarterly report will be submitted late nt q edgar us regulatory    pm proxy statement definitive def a edgar us regulatory    pm quarterly report q edgar us regulatory    pm notification that quarterly report will be submitted late nt q edgar us regulatory    pm powderbum   tuesday   am re none post  of   this is the biggest competing product to calmare httpswwwushealthtimescomneurontinandlyricaareadeathsentencefornewbrainsynapses ihub newswire drill targets at red cloud mine and exploration upside at magellans arizona silver projectmage jul    pm pura pps and vol up on momentum with possible retrace to  hightwmjf jul    am pura grow op acquisition w  million st yr outlook and  million near term growth plan presentation schedule july pura jul    am greenfield farms food discontinues insurance syndication merger talksgras jul    am in case you missed it  livewire ergogenics inc unveils new cannabis specific strategy to accelerate growth and enhance valuelvvv jul    am start posting your companys news only  per official company press release public reply  private reply  keep  last readpost new msgreplies   next   previous  next follow board keyboard shortcuts report tos violation x current price change volume detailed quote  discussion board  to watchlist   investorshubcom inc about investor relations about us terms of service privacy policy advertise with us data accreditations disclaimer help faq handbook qa forum contact us tutorials educational educational channel stock market  educational videos investor help forum personal finance qa more corporate solutions ihub on facebook ihub on twitter ihub iphoneipad app ihub android app ihub blackberry app ihub newswire you are guest on web   cttcotc us stock quote  calmare therapeutics inc  bloomberg markets error could not add to watchlist x  watchlist calmare therapeutics inc cttcus otc us usd   as of  pm edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share usd ttm  market cap m usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry health care equipment  services  price change  related videos there are currently no related videos for this ticker please check back later company news press releases there are currently no news stories for this ticker please check back later there are currently no press releases for this ticker please check back later profile calmare therapeutics incorporated provides patent and technology licensing and commercialization services the company identifies and markets technologies in life sciences including medical testing diagnostics pharmaceuticals biotechnologies medical devices and other medical applications address  kings highway eastfairfield ct united states phone  website wwwcalmaretherapeuticscom executives board members conrad f mir presidentceointerim cfo thomas p richtarich chief financial officer stephen j damato chief medical officer christine chansky chief regulatory officer show more cti  about cti  leadership homeabout∨profilewho we areboard of directorsservices∨overviewlicensingtechnology sourcingtechnologies∨featured technologiesportfolionews  press∨currentinvestors∨cti at a glanceboard of directorswho we aresec filingscorporate governanceinvestor contactscontact∨corporate officesinvestor contacts management conrad f mir president ceo and director thomas richtarich chief financial officer medical professionals stephen j damato md facep chief medical officer brandi a marino lpn assistant vice president director of nursing sales professionals william lipford product sales  us division head key personnel donna j mays manager administrative services quick links profile who we are board of directors sunday july rd  terms of service  privacy  legal  sitemap   copyright calmare therapeutics incorporated   calmare therapeutics inc cttcpk company profile  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states profile calmare therapeutics inc cttcpk related topics stocksstock screenerhealthcareadvanced medical equipment  technology overview news key developments people charts financials analysts research pulse cttcpk on otc markets group usd  jul  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  full description calmare therapeutics incorporated cti incorporated on august   is a medical device company the company is engaged in developing and commercializing products and technologies for chronic neuropathic pain and wound care affliction patients the companys medical device the calmare pain therapy device the calmare device is a noninvasive and nonaddictive modality that can treat chronic neuropathic pain its medical devices offer a nonpharmacological no drugs nonaddictive no narcotics and noninvasive over the skin solution to chronic pain sufferers in an outpatient treatment setting its subsidiary is vector vision incthe company offers a portfolio of technologies in life electronic nano and physical sciences the companys technology portfolio includes calmare pain therapy treatment neuroprotection and cognitive enhancement sexual dysfunction therapeutic skin pigment enhancer wound sealant preparation of ordered multilayer films silica thin films structural steel fissure detection paint public key encryption growing single crystals and video compression and moving picture experts group mpeg its pain therapy technology is a noninvasive method for treatment of oncologic neuropathic and drugresistant pain through a biophysical rather than a biochemical manner » full overview of cttcpk company address calmare therapeutics inc  kings hwyfairfield   ct    p f  company web links home page officers  directors name compensation peter brennan  conrad mir  thomas richtarich  stephen damato  carl oconnell  » more officers  directors calmare therapeutics inc news » more cttcpk news related topics stocksstock screenerhealthcareadvanced medical equipment  technology omqstuttgart stock quote  calmare therapeutics inc  bloomberg markets error could not add to watchlist x  watchlist calmare therapeutics inc omqgr stuttgart price not available for omqgr eur volume  before its here its on the bloomberg terminal learn more volume  current pe ratio ttm  earnings per share usd ttm  market cap eur  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry health care equipment  services  price change  related videos there are currently no related videos for this ticker please check back later company news press releases there are currently no news stories for this ticker please check back later there are currently no press releases for this ticker please check back later profile calmare therapeutics incorporated provides patent and technology licensing and commercialization services the company identifies and markets technologies in life sciences including medical testing diagnostics pharmaceuticals biotechnologies medical devices and other medical applications address  kings highway eastfairfield ct united states phone  website wwwcalmaretherapeuticscom executives board members conrad f mir presidentceointerim cfo thomas p richtarich chief financial officer stephen j damato chief medical officer christine chansky chief regulatory officer show more calmare  doctor info homepain relief∨who its forhow it workspatient testimonialsabout∨media gallerypatient qaabout calmareabout ctifacilities∨treatment facilities » centers of excellence » medical » research » us military and va » chiropracticfind a providerdoctor info∨publicationsclinical trialspresentationsqareference materialsmedical equipmentcontact∨calmareus salesgovernment salesinternational treatment utilizing the calmare® medical device is restricted to allopathic or osteopathic physicians and other qualified licensed healthcare professionals under their direct supervision who are certified in its use and application and are familiar with the principles clinical applications side effects and hazards associated with transdermal pain modulation publications clinical trials presentations reference materials medical equipment decreased low back pain intensity and differential gene expression following calmare® results from a doubleblinded randomized shamcontrolled study angela r starkweather patrick coyne debra e lyon r k elswick jr kyungeh an jamie sturgill res nurs health   pmid  doi nur treatment of postherpetic pain with scrambler therapy a patientspecific neurocutaneous electrical stimulation device thomas j smith md giuseppe marineo scd am j hosp palliat care  jul  epub ahead of print pmid  doi  clinical experiences on the effect of scrambler therapy for patients with postherpetic neuralgia young kwon ko md ho young lee md and wang yong lee md korean j pain  jan pmid  pmcid pmc doi kjp scrambler therapy may relieve chronic neuropathic pain more effectively than guidelinebased drug management results of a pilot randomized controlled trial giuseppe marineo phd vittorio iorno md cristiano gandini md vincenzo moschini md and thomas j smith md j pain symptom manage  jan pii s doi jjpainsymman pilot trial of a patientspecific cutaneous electrostimulation device mca calmare® for chemotherapyinduced peripheral neuropathy thomas j smith md patrick j coyne rn msn gwendolyn l parker rn msn patricia dodson rn msn and viswanathan ramakrishnan phd j pain symptom manage  dec pii sx pmid  doi jjpainsymman scrambler therapy a f sabato g marineo a gatti minerva anestesiol  julaug pmid  untreatable pain resulting from abdominal cancer new hope from biophysics giuseppe marineo jop  jan pmid  artificial neurons in oncological pain the potential of scrambler therapy to modify a biological information g marineo s spaziani af sabato f marotta international congress series    doi s scrambler therapy in the treatment of chronic chemotherapyinduced peripheral neuropathy nct id nct sponsor sidney kimmel comprehensive cancer center johns hopkins principal investigator thomas j smith protocol ids j na trial of scrambler therapy or sham treatment for low back pain nct id nct sponsor virginia commonwealth university school of nursing principal investigator angela starkweather protocol ids scralbp scrambler therapy in treating chronic pain in patients with rash from varicella zoster virus infection nct id nct sponsor mayo clinic principal investigator charles l loprinzi protocol ids mcce nci scrambler therapy in treating pain and peripheral neuropathy in patients previously treated with chemotherapy nct id nct sponsor mayo clinic principal investigator charles l loprinzi protocol ids mccc nci mca scrambler therapy in reducing peripheral neuropathy caused by chemotherapy nct id nct sponsor mayo clinic principal investigator charles l loprinzi protocol ids mcc nci  mca for chemotherapy induced peripheral neuropathy nct id nct sponsor university of wisconsin madison principal investigator toby campbell protocol ids os electrical stimulation pain therapy in treating chronic pain and numbness caused by chemotherapy in patients with cancer nct id nct sponsor virginia commonwealth university massey cancer center principal investigator craig swainey protocol ids mcc nci electrical stimulation therapy using the mca scrambler in reducing peripheral neuropathy caused by chemotherapy nct id nct sponsor virginia commonwealth university massey cancer center principal investigator thomas j smith protocol ids cdr mcvmcc treatment of chronic neuropathic pain caused by chemotherapy competitive technologies inc corneal neuropathic pain perry rosenthal md boston foundation for sight harvard medical school mca for painful chemotherapyinduced peripheral neuropathy toby campbell md msci paul carbone cancer center university of wisconsin application of information theory in pain therapy stephen j damato md calmar pain relief llc product brochure recommended treatment protocol q  a poster calmare pain therapy medical device product code mca calmare® pain therapy medical device is us fda kcleared and european ce markcertified for the treatment of oncologic and neuropathic pain through biophysical stimulation the device has five separate channels convenient dial selectors with five corresponding channel meters indicator lights and an lcd display to monitor operation shown without optional cart deluxe calmare device cart product code k designed for ease of use the deluxe calmare device cart adds mobility and storage to the calmare pain therapy medical device this premium quality medical cart has highmobility castors that lock and unlock with ease and doorenclosure storage compartments medical electrodes product code cti size  x  oval quantity case axelgaard little pals® snap electrodes white fabric top great fit for small contact areas fingers and toes good match with calmare device semireuseable can be moved during treatment session product code cti size  x  square quantity case axelgaard ultrastim® snap electrodes white fabric top great match with calmare device reusable eg over the typical  treatment regiment enhanced distribution of the electric current  eliminating hotspots cost effective compared to disposible electrodes product code cti size  x  rectangle quantity case axelgaard ultrastim® snap electrodes white fabric top great match with calmare device reusable eg over the typical  treatment regiment enhanced distribution of the electric current  eliminating hotspots cost effective compared to disposible electrodes medical leadwire product code mcw snaptype lead wire with colored connectors sunday july rd  terms of service  privacy  legal  sitemap    cti copyright calmare therapeutics incorporated   calmare therapeutics inc cttc market data  news  equitiescom breaking news previous next stocks end mixed as earnings season begins ​sec investigates registration violations in eb offerings this time it is different aptevo therapeutics apvo codeveloping new immunooncology drug with alligator bioscience  key differences between founding a forprofit and a nonprofit startup usglobal canada companies log in login to your account log in remember me forgot your password forgot your username register calmare therapeutics inc cttc  follow x close by  profile calmare therapeutics inc along with its subsidiaries is a biotherapeutic company it is engaged in developing and commercializing products and technologies for chronic neuropathic pain and wound care affliction patients contact information website wwwcalmaretherapeuticscom email infocorpirservicescom main phone    address  kings highway east address  suite  state ct city  town fairfield country usa postal code  issuer information exchange otcqb employees  naics pharmaceutical p      d d d mo mo mo y y max last price  change   change   tick na bid na bid size na ask na ask size na open  high  low  prev close  last trade jul   volume   wk hi   wk low  market cap  mi exdiv date na div rate na yield na shares  eps ttm  pe ratio na exchange otcpk estimates filings analysts   current  week ago  weeks ago  weeks ago high target price estimate     low target price estimate     mean target price estimate     standard deviation     date of most recent estimate     form type form description pages date q quarterly report with a continuing view of a companys financial position   nt q notification that form q will be submitted late   q quarterly report with a continuing view of a companys financial position   nt q notification that form q will be submitted late   k annual report with a comprehensive overview of the company   nt k notification that form k will be submitted late   q quarterly report with a continuing view of a companys financial position   sc g statement of beneficial ownership of common stock by certain persons   k report of unscheduled material events or corporate changes   q quarterly report with a continuing view of a companys financial position     current  month ago  months ago  months ago strong buy     moderate buy     hold     moderate sell     strong sell     mean rec     news calmare therapeutics board of directors changes february     calmare therapeutics medical device and peripherals now listed for sale on gsa advantager web portal january     calmare therapeutics medical device and peripherals now listed for sale on gsa advantager web portal january     calmare therapeutics reports third quarter  results january     calmare therapeutics reports third quarter  results january     calmare therapeutics reports second quarter  results august     calmare therapeutics reports second quarter  results august     seethruequity conference brings together microcap companies and investors in new york city june     calmare therapeutics incorporated uplists may     calmare therapeutics reports q results may     popular tweets  fetching no one is talking about this yet × you must log in first im sorry but in order to complete what youre trying to do you must be logged in take me to log in dont have an account im good for now corporate sitepremium productsadvertisingrss feeds aboutcontactsite maptestimonials privacy policyterms and conditionsdisclaimerconference   equities  all dates and time are being displayed in eastern standard time est cttc stock price  calmare therapeutics inc stock quote us otc  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y djia f    sp f    nasdaq f    gold    silver    crude oil    sp  movers ctas  cof  etfc  syf  hp  isrg  hban  chk  latest newsall times eastern a alphabet earnings a  billion hit for google potential youtube results for investors a updated surprise those ‘great’ companies generally turn out to be meh  or duds a updated this is how congress could create a bipartisan healthcare bill a updated  fears an ai developer has about artificial intelligence a updated exhealth insurance ceo  common but faulty beliefs about paying for health care a updated draining the swamp starts with blowing up health care a updated these  highly taxed companies need congress to finally act on tax reform a updated beyond tesla  stocks driving the autonomous car revolution a opinion fifty years after the riots detroit is finally rising out of the devastation a your next online order could be picked out by a robot to be replaced home investing quotes stocks united states cttc overview compare quotes stock screener earnings calendar sectors cttc us otc join td ameritrade find a broker calmare therapeutics inc watchlist createcttcalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta na rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest na na  of float shorted na average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones fund manager finding few bargains among smallcap stocks dec   at  pm et by marketwatch overvalued smallcaps dec   at  pm et by bill disbrow biotech stocks close lower genentech rises oct   at  pm et by val brickates kennedy biotech pharma decline pfizer dips jun   at  pm et by val brickates kennedy competitive technologies sued by sec for stock buyback aug   at  am et by heather wilson competitive tech to get m from court ruling jun   at  pm et by carla mozee competitive tech wins patent suit against labcorp jun   at  pm et by carla mozee is asia out of the woods  dec   at  pm et by julie rannazzisi movers and shakers  dec   at  pm et by cbsmarketwatchcom commentary zapman thinks we should cenure darlene  dec   at  pm et by cbsmarketwatchcom movers and shakers  dec   at  pm et by cbsmarketwatchcom soapbox fund managers fight back with ballot box  dec   at  pm et by craig tolliver your fund manager is paid too much dec   at  pm et by dr paul b farrell whos news briefs nov   at  am et on the wall street journal recent news other news press releases k calmare therapeutics inc k calmare therapeutics inc jul   at  pm et on edgar online  edg  q k q calmare therapeutics inc dec   at  pm et on edgar online  edg  q k q calmare therapeutics inc aug   at  pm et on edgar online  edg  q k innerworkings inwk in focus stock jumps   tale of the tape jan   at  am et on zackscom lb foster boosts inorganic growth on tew engineering buy  analyst blog jan   at  pm et on zackscom turnaround strategy being implemented at competitive technologies mar   at  am et on seeking alpha wns holdings beats fiscal q earnings revs up yy  analyst blog jan   at  pm et on zackscom wpp down to buy  analyst blog jan   at  am et on zackscom furmanite corp frm in focus stock up  in session  tale of the tape jan   at  am et on zackscom soufun prices senior notes  analyst blog dec   at  pm et on zackscom wns holdings upped to buy  analyst blog dec   at  pm et on zackscom soufun shares hit week high  analyst blog dec   at  am et on zackscom competitive technologies ceo discusses q  results  earnings call transcript nov   at  pm et on seeking alpha inline q loss at competitive technologies  analyst blog nov   at  am et on zackscom poor q for competitive technologies  analyst blog aug   at  pm et on zackscom competitive technologies short squeeze coming or another leg down aug   at  am et on seeking alpha pain relief coming at competitive technologies jul   at  am et on seeking alpha competitive technologies a game changer in pain management may   at  pm et on seeking alpha competitive technologies up on shareholder meeting pending asco presentation apr   at  am et on seeking alpha competitive technologies is the pain over apr   at  am et on seeking alpha no headlines available calmare therapeutics inc calmare therapeutics inc is a medical device company which develops and distributes products and technologies for chronic neuropathic pain and wound care affliction patients its product device calmare pain therepy device is noninvasive and nonaddictive modality that treats chronic neuropathic pain the company was founded in  and is headquartered in fairfield ct see full profile competitors name chg  market cap acacia research corp  acacia technologies  m franchise holdings international inc  m rpx corp  m competitor data provided by partner content trending tickers powered by cr  logm  ilmn  cms  mac  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aalphabet earnings a  billion hit for google potential youtube results for investors asurprise those ‘great’ companies generally turn out to be meh  or duds athis is how congress could create a bipartisan healthcare bill a fears an ai developer has about artificial intelligence aexhealth insurance ceo  common but faulty beliefs about paying for health care adraining the swamp starts with blowing up health care athese  highly taxed companies need congress to finally act on tax reform abeyond tesla  stocks driving the autonomous car revolution afifty years after the riots detroit is finally rising out of the devastation ayour next online order could be picked out by a robot a costly mistakes people make when buying cars awhat’s a cameo – like ed sheeran on game of thrones – actually worth ptrump says he has ‘complete power to pardon’ plawmakers reach deal on russia sanctions bill reports palphabet earnings a  billion hit for google potential youtube results for investors pyou can date someone who looks just like donald trump with this new online service pwant to buy happiness splurge on these  things pthis is what people really buy when they emotionally overspend hint it’s not designer clothes pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aalphabet earnings a  billion hit for google potential youtube results for investors asurprise those ‘great’ companies generally turn out to be meh  or duds athis is how congress could create a bipartisan healthcare bill a fears an ai developer has about artificial intelligence aexhealth insurance ceo  common but faulty beliefs about paying for health care adraining the swamp starts with blowing up health care athese  highly taxed companies need congress to finally act on tax reform abeyond tesla  stocks driving the autonomous car revolution afifty years after the riots detroit is finally rising out of the devastation ayour next online order could be picked out by a robot a costly mistakes people make when buying cars awhat’s a cameo – like ed sheeran on game of thrones – actually worth ptrump says he has ‘complete power to pardon’ plawmakers reach deal on russia sanctions bill reports palphabet earnings a  billion hit for google potential youtube results for investors pyou can date someone who looks just like donald trump with this new online service pwant to buy happiness splurge on these  things pthis is what people really buy when they emotionally overspend hint it’s not designer clothes pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aalphabet earnings a  billion hit for google potential youtube results for investors asurprise those ‘great’ companies generally turn out to be meh  or duds athis is how congress could create a bipartisan healthcare bill a fears an ai developer has about artificial intelligence aexhealth insurance ceo  common but faulty beliefs about paying for health care adraining the swamp starts with blowing up health care athese  highly taxed companies need congress to finally act on tax reform abeyond tesla  stocks driving the autonomous car revolution afifty years after the riots detroit is finally rising out of the devastation ayour next online order could be picked out by a robot a costly mistakes people make when buying cars awhat’s a cameo – like ed sheeran on game of thrones – actually worth ptrump says he has ‘complete power to pardon’ plawmakers reach deal on russia sanctions bill reports palphabet earnings a  billion hit for google potential youtube results for investors pyou can date someone who looks just like donald trump with this new online service pwant to buy happiness splurge on these  things pthis is what people really buy when they emotionally overspend hint it’s not designer clothes pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  cttc stock price  calmare therapeutics inc stock quote us otc  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y djia f    sp f    nasdaq f    gold    silver    crude oil    sp  movers ctas  cof  etfc  syf  hp  isrg  hban  chk  latest newsall times eastern a alphabet earnings a  billion hit for google potential youtube results for investors a updated surprise those ‘great’ companies generally turn out to be meh  or duds a updated this is how congress could create a bipartisan healthcare bill a updated  fears an ai developer has about artificial intelligence a updated exhealth insurance ceo  common but faulty beliefs about paying for health care a updated draining the swamp starts with blowing up health care a updated these  highly taxed companies need congress to finally act on tax reform a updated beyond tesla  stocks driving the autonomous car revolution a opinion fifty years after the riots detroit is finally rising out of the devastation a your next online order could be picked out by a robot to be replaced home investing quotes stocks united states cttc overview compare quotes stock screener earnings calendar sectors cttc us otc join td ameritrade find a broker calmare therapeutics inc watchlist createcttcalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta na rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest na na  of float shorted na average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones fund manager finding few bargains among smallcap stocks dec   at  pm et by marketwatch overvalued smallcaps dec   at  pm et by bill disbrow biotech stocks close lower genentech rises oct   at  pm et by val brickates kennedy biotech pharma decline pfizer dips jun   at  pm et by val brickates kennedy competitive technologies sued by sec for stock buyback aug   at  am et by heather wilson competitive tech to get m from court ruling jun   at  pm et by carla mozee competitive tech wins patent suit against labcorp jun   at  pm et by carla mozee is asia out of the woods  dec   at  pm et by julie rannazzisi movers and shakers  dec   at  pm et by cbsmarketwatchcom commentary zapman thinks we should cenure darlene  dec   at  pm et by cbsmarketwatchcom movers and shakers  dec   at  pm et by cbsmarketwatchcom soapbox fund managers fight back with ballot box  dec   at  pm et by craig tolliver your fund manager is paid too much dec   at  pm et by dr paul b farrell whos news briefs nov   at  am et on the wall street journal recent news other news press releases k calmare therapeutics inc k calmare therapeutics inc jul   at  pm et on edgar online  edg  q k q calmare therapeutics inc dec   at  pm et on edgar online  edg  q k q calmare therapeutics inc aug   at  pm et on edgar online  edg  q k innerworkings inwk in focus stock jumps   tale of the tape jan   at  am et on zackscom lb foster boosts inorganic growth on tew engineering buy  analyst blog jan   at  pm et on zackscom turnaround strategy being implemented at competitive technologies mar   at  am et on seeking alpha wns holdings beats fiscal q earnings revs up yy  analyst blog jan   at  pm et on zackscom wpp down to buy  analyst blog jan   at  am et on zackscom furmanite corp frm in focus stock up  in session  tale of the tape jan   at  am et on zackscom soufun prices senior notes  analyst blog dec   at  pm et on zackscom wns holdings upped to buy  analyst blog dec   at  pm et on zackscom soufun shares hit week high  analyst blog dec   at  am et on zackscom competitive technologies ceo discusses q  results  earnings call transcript nov   at  pm et on seeking alpha inline q loss at competitive technologies  analyst blog nov   at  am et on zackscom poor q for competitive technologies  analyst blog aug   at  pm et on zackscom competitive technologies short squeeze coming or another leg down aug   at  am et on seeking alpha pain relief coming at competitive technologies jul   at  am et on seeking alpha competitive technologies a game changer in pain management may   at  pm et on seeking alpha competitive technologies up on shareholder meeting pending asco presentation apr   at  am et on seeking alpha competitive technologies is the pain over apr   at  am et on seeking alpha no headlines available calmare therapeutics inc calmare therapeutics inc is a medical device company which develops and distributes products and technologies for chronic neuropathic pain and wound care affliction patients its product device calmare pain therepy device is noninvasive and nonaddictive modality that treats chronic neuropathic pain the company was founded in  and is headquartered in fairfield ct see full profile competitors name chg  market cap acacia research corp  acacia technologies  m franchise holdings international inc  m rpx corp  m competitor data provided by partner content trending tickers powered by cr  logm  ilmn  cms  mac  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience cti  the pain mitigation company  home homeabout∨profilewho we areboard of directorsservices∨overviewlicensingtechnology sourcingtechnologies∨featured technologiesportfolionews  press∨currentinvestors∨cti at a glanceboard of directorswho we aresec filingscorporate governanceinvestor contactscontact∨corporate officesinvestor contacts calmare therapeutics incorporated otcqb cttc cti is a biotherapeutic company furthering proprietary and patented pain mitigation and wound care technologies our medical devices offer a nonpharmacological no drugs nonaddictive no narcotics and noninvasive “over the skin” solution to chronic pain sufferers in an outpatient treatment setting cti supplements our medical devices with a catalogue of private label neurostimulation and sensory electrodes the company has fda k medical clearance k for sales in the united states and reciprocity countries for its flagship medical device  the calmare® pain therapy device we sell our devices in europe under cemark designation that was issued by the european commission’s competitiveness and innovation program in  commercial sales are also made throughout the world under the guidance and jurisdiction of the respective countries’ ministry of health department for more information on the device visit wwwcalmarepmtcom the company has been a preferred vendor of the us federal government gsavpb since  devices consumables and related hardware are sold to us military hospitals and clinics throughout the united states the calmare® pain therapy device provides excellent pain treatment efficacy through a noninvasive procedure which successfully treats pain without harmful side effects or the use of powerful and potentially addictive drugs dr jonathan kost of the hartford hospital pain treatment center discusses use of the calmare pain therapy device in the treatment of chemotherapyinduced peripheral neuropathy whats new cti board of directors changes cti medical device and peripherals listed for sale on gsa advantage® cti reports rd quarter  results media coverage ehealth radio interviews dr stephen damato chief medical officer of calmare therapeutics the osgood file hosted by charles osgood on the cbs radio network covers research utilizing the calmare® pain therapy medical device being conducted at the mayo clinic the syndicated television show the doctors interviews dr jack dangelo and discusses his use of the calmare® pain therapy medical device to treat complex regional pain syndrome follow cti  sunday july rd  terms of service  privacy  legal  sitemap   copyright calmare therapeutics incorporated   bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one